Life Technologies Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Life Technologies Corporation - overview
Location
Carlsbad, CA, US
Primary Industry
Biotechnology
About
Life Technologies Corporation is a biopharmaceutical company specializing in providing innovative solutions for genomics, proteomics, and molecular biology to enhance research and clinical diagnostics worldwide. Life Technologies Corporation is dedicated to advancing the field of life sciences by offering a broad range of products including reagents, instruments, and software for DNA sequencing and analysis. The company was co-founded by Deby Page and Lilian Delaveau, and operates from its headquarters in Carlsbad, California, US. Life Technologies has undergone strategic pivots to enhance its operations, focusing on expanding its product offerings to support emerging scientific needs.
Life Technologies Corporation provides a comprehensive portfolio of scientific instrumentation, reagents, and consumables aimed at the biotechnology, pharmaceutical, and clinical diagnostics sectors. Their offerings include lab equipment, chemicals, antibodies, cell culture media, and molecular testing solutions which are essential for improving workflow efficiency in research and development. Notable products include advanced mass spectrometry systems and tailored media solutions, serving a diverse clientele across North America, Europe, and Asia-Pacific. Life Technologies Corporation generates revenue through a diversified model that includes direct sales to healthcare institutions, research organizations, and a wide range of B2B transactions.
Their pricing structures reflect the specialization of their products, with offerings such as custom qPCR assays and laboratory equipment contributing significantly to their revenue streams. Life Technologies Corporation is focused on releasing new products designed for advanced genomics and protein analysis. The company plans to expand into emerging markets in Asia and Latin America by 2025, leveraging recent funding to support research and development for innovative solutions in these regions. The investments will also facilitate enhancements in their existing product lines and the establishment of local partnerships to better serve new and existing customers.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.lifetechnologies.com
Total Amount Raised
Subscriber access only
Life Technologies Corporation - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.